(Q37737994)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jan Lunemann

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

Björn Tackenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

30 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

S65-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10875-010-9398-1

1 February 2020

exact match

0 references

cites work

Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-010-9398-1

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-010-9398-1

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

12 December 2020

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

1 reference

12 December 2020

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation

1 reference

12 December 2020

Divergent immunoglobulin g subclass activity through selective Fc receptor binding

1 reference

12 December 2020

The impact of glycosylation on the biological function and structure of human immunoglobulins.

1 reference

12 December 2020

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study

1 reference

12 December 2020

Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura.

1 reference

12 December 2020

Chronic inflammatory polyradiculoneuropathy

1 reference

12 December 2020

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

12 December 2020

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

1 reference

12 December 2020

Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis

1 reference

12 December 2020

Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

1 reference

12 December 2020

Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII

1 reference

12 December 2020

Agalactosyl glycoforms of IgG autoantibodies are pathogenic

1 reference

12 December 2020

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

1 reference

12 December 2020

From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerve

1 reference

12 December 2020

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

1 reference

12 December 2020

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

12 December 2020

Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice.

1 reference

12 December 2020

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

1 reference

12 December 2020

Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE

1 reference

12 December 2020

Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease

1 reference

12 December 2020

Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population

1 reference

12 December 2020

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

1 reference

12 December 2020

Clinical spectrum of chronic acquired demyelinating polyneuropathies

1 reference

12 December 2020

The complement system in regulation of adaptive immunity

1 reference

12 December 2020

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

1 reference

12 December 2020

Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

1 reference

12 December 2020

Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients.

1 reference

12 December 2020

Incidence and prevalence of CIDP and the association of diabetes mellitus

1 reference

12 December 2020

Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein

1 reference

12 December 2020

Chronic inflammatory demyelinating polyneuropathy.

1 reference

12 December 2020

Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis

1 reference

12 December 2020

Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy

1 reference

12 December 2020

Fcgamma receptors as regulators of immune responses

1 reference

12 December 2020

10.1007/S10875-010-9398-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424898%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference